|
|
|
|
| LEADER |
01386cam a2200349 4500 |
| 001 |
PPN138893861 |
| 005 |
20160915031900.0 |
| 010 |
|
|
|a 978-2-7040-1266-4
|b br.
|d 29 EUR
|
| 073 |
|
0 |
|a 9782704012664
|
| 100 |
|
|
|a 20091130h20092009k y0frey0103 ba
|
| 101 |
0 |
|
|a fre
|
| 102 |
|
|
|a FR
|
| 105 |
|
|
|a a ||||000yy
|
| 106 |
|
|
|a r
|
| 200 |
1 |
|
|a Infection VIH
|b Texte imprimé
|e mémento thérapeutique 2009
|f Jean-Michel Dariosecq,... Anne-Marie Taburet,... Pierre-Marie Girard,...
|
| 205 |
|
|
|a 9e édition
|
| 210 |
|
|
|a Rueil-Malmaison
|c Doin
|d impr. 2009
|
| 215 |
|
|
|a 1 vol. (470 p. )
|c ill. en coul., couv. ill. en coul.
|d 21 cm
|e dépliant
|
| 606 |
|
|
|3 PPN035252073
|a Antirétroviraux
|2 rameau
|
| 606 |
|
|
|3 PPN031700152
|a Infections à HIV
|3 PPN027589838
|x Thérapeutique
|2 rameau
|
| 606 |
|
|
|3 PPN031700152
|a Infections à HIV
|3 PPN027413756
|x Chimiothérapie
|2 rameau
|
| 606 |
|
|
|3 PPN040806391
|a Infections à VIH
|3 PPN038961792
|x thérapie
|2 fmesh
|
| 606 |
|
|
|3 PPN040838595
|a Agents antiVIH
|3 PPN038961784
|x usage thérapeutique
|2 fmesh
|
| 686 |
|
|
|a WC 503
|2 usnlm
|
| 686 |
|
|
|a WC 503.2
|2 usnlm
|
| 700 |
|
1 |
|3 PPN034295488
|a Dariosecq
|b Jean-Michel
|4 070
|
| 701 |
|
1 |
|3 PPN055677541
|a Taburet
|b Anne-Marie
|4 070
|
| 701 |
|
1 |
|3 PPN033024227
|a Girard
|b Pierre-Marie
|4 070
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20100721
|g AFNOR
|
| 930 |
|
|
|5 441092101:408264284
|b 441092101
|a WC 503 DAR
|j u
|
| 979 |
|
|
|a SAN
|
| 998 |
|
|
|a 588525
|
Nantilus
